BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33329391)

  • 1. Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis.
    Yumiceba V; López-Cortés A; Pérez-Villa A; Yumiseba I; Guerrero S; García-Cárdenas JM; Armendáriz-Castillo I; Guevara-Ramírez P; Leone PE; Zambrano AK; Paz-Y-Miño C
    Front Endocrinol (Lausanne); 2020; 11():585130. PubMed ID: 33329391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
    Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
    Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
    Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis.
    Zou J; Li Y; Liao N; Liu J; Zhang Q; Luo M; Xiao J; Chen Y; Wang M; Chen K; Zeng J; Mo Z
    J Ovarian Res; 2022 Feb; 15(1):30. PubMed ID: 35227296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
    Rosenfield RL
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):412-9. PubMed ID: 25840648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the Role of Insulin-Like Growth Factor 1 in Endometrial Cancer in Patients With Polycystic Ovary Syndrome: Protocol for a Methodological Approach Using Cell Culture Experiments.
    Atiomo W; Alqutami F; Albasha S; Hachim M
    JMIR Res Protoc; 2023 Nov; 12():e48127. PubMed ID: 37988160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case-Control Study and In Silico Analyses.
    Biglari-Zadeh G; Sargazi S; Mohammadi M; Ghasemi M; Majidpour M; Saravani R; Mirinejad S
    Biochem Genet; 2023 Oct; 61(5):1827-1849. PubMed ID: 36856940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
    Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
    Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome and mitochondrial dysfunction.
    Zhang J; Bao Y; Zhou X; Zheng L
    Reprod Biol Endocrinol; 2019 Aug; 17(1):67. PubMed ID: 31420039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic research in PCOS: are we reaching new frontiers?
    Ben-Shlomo I; Younis JS
    Reprod Biomed Online; 2014 Jun; 28(6):669-83. PubMed ID: 24768413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.